TCTR20230217001已完成3 期
Effect of Menaquinone-7 Supplementation on Arterial Stiffness in Chronic Hemodialysis patients: A Multicenter Randomized Controlled Trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 86
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •Age equal or more than 18 years at screening
- •Undergoing maintenance HD at least 2 times a week for more than 1 month prior to screening and compliance with HD treatments
- •cfPWV measurement equal or more than 10 m/s at screening visit
排除标准
- •Pregnancy and breastfeeding
- •Receiving vitamin K antagonist or warfarin
- •Receiving and/or history of vitamin K supplementation in 3 months before screening
- •History of percutaneous coronary intervention and/or coronary artery bypass grafting
- •Patients with conditions that were unable to assess cfPWV including deformity of peripheral limbs, amputation, and severe peripheral vascular disease.
研究者
相似试验
已完成
不适用
effect of Menaquinone(MK-7) supplementation on deppression status in patients with polycystic ovary syndromeIRCT20170916036204N5Shiraz University of Medical Sciences84
已完成
不适用
The Aortic Valve DECalcification (AVADEC) TrialAortic Valve StenosisMultidetector Computed TomographyVitamin K 2Randomised Clinical TrialNCT03243890Axel Diederichsen389
已完成
不适用
The DANish COronary DEcalcification (DANCODE) TrialCoronary Artery DiseaseNCT05500443Odense University Hospital400
招募中
3 期
Effect of menaquinone supplementation in DMIIType II Diabetes.Diabetes mellitus due to underlying conditionIRCT20100123003140N22Tabriz University of Medical Sciences46
已完成
不适用
Impact of Ubiquinol Supplementation on Endothelial Function in Subjects at Risk of Cardiovascular Disease DevelopmentEndothelial DysfunctionCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemMetabolic and Endocrine - Metabolic disordersDyslipidemiaACTRN12619000436178I.N.R.C.A. (Italian National Research Centre on Aging)-IRCCS51